Table 2.
Disease and Clinical Related Characteristics of TB Pediatrics Patients Attending NSH, 2019
| Variables | Frequency (n) | Percent (%) | |
|---|---|---|---|
| Side effect | Yes | 126 | 62.4 |
| No | 76 | 37.6 | |
| Type of side effect (n=126) | NVD | 55 | 27.2 |
| Changed eye color | 27 | 13.4 | |
| Other | 44 | 21.8 | |
| Disease classification | PTB-SM+ | 24 | 11.9 |
| PTB-SM- | 12 | 5.9 | |
| EPTB | 166 | 82.2 | |
| Pre-treatment Smear result | Smear positive | 64 | 31.7 |
| Smear negative | 17 | 8.4 | |
| Not done | 121 | 59.9 | |
| Treatment phase | Intensive | 174 | 86.1 |
| Continuous | 28 | 13.9 | |
| HIV status | Positive | 10 | 5 |
| Negative | 192 | 95 | |
| Medicines besides TB treatment | Yes | 15 | 7.4 |
| No | 187 | 92.6 | |
| Total | 202 | 100 | |
| Medicine was taking for (n=15) | HAART | 10 | 66.7 |
| Multivitamins | 5 | 33.3 |
Abbreviations: HAART, highly active ant-retroviral therapy; NVD, nausea, vomiting, and diarrhea; EPTB, extrapulmonary tuberculosis; PTB-SM+, smear positive pulmonary tuberculosis; PTB-SM-, smear negative pulmonary tuberculosis.